Will Production Bottlenecks For BMS’s Abecma Pose Problems After EU Approval?

Abecma has won conditional approval in the EU for certain multiple myeloma patients

First CAR-T therapy for multiple myeloma faces capacity constraints in the US • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip